Simona Corinti joins NIB Biotec

Simona Corinti recently announced her entry into NIB Biotec, an innovative biomedical start-up, leaving Gilead Sciences where she held the role of Finance Director Controllership.

Simona has gained vast and consolidated experience in the financial sector in the pharmaceutical and biotechnology sector, working for years in leadership roles at various multinationals. His expertise and ability to lead teams to success will be critical to the future of NIB Biotec.

As a new member of the team, Simona will bring her experience in financial and strategic management, helping to strengthen NIB Biotec's position in the Italian and European markets. His vision and commitment will be crucial to the industrialization and commercialization of ZenPSA-pro test, il test diagnostico per il prostate cancer.

Simona Corinti's entry into NIB Biotec represents a perfect synergy between experience and innovation. With her contribution, the company adds further value and expertise that will allow it to successfully face future challenges and continue to develop cutting-edge solutions to improve diagnoses and treatments for prostate cancer.